The Ministry of Chemicals and Fertilizers has made adequate allocation of Remdesivir injection till May 23 for the treatment of Covid patients, it said.
Considering the requirement of Remdesivir in every state and ensuring its adequate availability, Union Minister of Chemicals & Fertilisers D.V Sadananda Gowda on Sunday announced the allocation of Remdesivir and said substantial increase has been made in overall production and allocation of the drug, crucial in treatment of Covid patients.
In a letter to all States by Department of Pharmaceuticals and Ministry of Health and Family Welfare, it was mentioned that in continuation of the allocation plan of Remdesivir drug for the period -- April 21 to May 16, 2021 communicated by D.O on May 7 2021, an updated allocation plan valid for the period -- April 21 to May May 21, 2021 is prepared jointly by the Department of Pharmaceuticals and Ministry of Health and Family Welfare.
The allotment has been made for the States/UTs and they have been asked to monitor proper distribution covering government and private hospitals as appropriate and in line with judicious use.
State governments/UTs have been advised to place adequate purchase orders with the marketing companies immediately, if they have not already done so, for the quantity that they want to purchase out of allocation for the State/UT as per supply chain in close coordination with liaison officers of the companies. The coordination with private distribution channel in the state could also be made.
--IANS
miz/skp/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)